Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential role of the inactivated X chromosome in ovarian epithelial tumor development.

Journal of the National Cancer Institute - 17 Apr 1996

Cheng P C, Gosewehr J A, Kim T M, Velicescu M, Wan M, Zheng J, Felix J C, Cofer K F, Luo P, Biela B H, Godorov G, Dubeau L

Abstract excerpt

BACKGROUND: Ovarian epithelial tumors can be divided into subcategories often regarded as different stages of neoplastic transformation. Cystadenomas belong to the least aggressive subgroup and are noninvasive and nonmetastatic. Ovarian tumors of low malignant potential (LMP) are intermediate between cystadenomas and carcinomas and show markedly reduced invasive and metastatic abilities. Invasion and metastasis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Base Sequence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma

Share to Chromosome Deletion

Share to Molecular Sequence Data

Share to Ovarian Neoplasms

Share to X Chromosome

Source

Identifiers

PMID: 8606379
DOI: 10.1093/jnci/88.8.510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential role of the inactivated X chromosome in ovarian epithelial tumor development.PMID 8606379Read ↗

Comprehensive allelotype study of ovarian tumors of low malignant potential: potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma.Semantic proximity Read ↗

Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.Semantic proximity Read ↗

Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian CancerSemantic proximity Read ↗

Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations.Semantic proximity Read ↗

Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome.Semantic proximity Read ↗

Molecular genetic changes in human epithelial ovarian malignancies.Semantic proximity Read ↗

Imprinted tumor suppressor genes <i>ARHI</i> and <i>PEG3</i> are the most frequently down‐regulated in human ovarian cancers by loss of heterozygosity and promoter methylationSemantic proximity Read ↗

Human epithelial ovarian cancer allelotype.Semantic proximity Read ↗

Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region.Semantic proximity Read ↗

Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.Semantic proximity Read ↗

A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors.Semantic proximity Read ↗

Accumulated allelic losses in the development of invasive urothelial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.